How the COVID-19 Pandemic Affected Prostate Cancer Screening and Access to CareEarly on in the COVID-19 pandemic in the United States, there was not much information available. Even experts were unsure of how COVID-19 was spread, who was at the highest... By Editorial Team 3 min readBookmark for laterReactions 0 reactions Comments1 comments
American Cancer Society Releases 2021 Report on CancerThe American Cancer Society (ACS) has released its 2021 report on cancer, called Cancer Facts and Figures 2021. The data in this report is 2 to 4 years behind the... By Editorial Team 3 min readBookmark for laterReactions 0 reactions Comments0 comments
COVID-19 Updates, July 16: Updates on People at Risk, Testing, Reopening, and a VaccineEven after months of navigating life in the COVID-19 era, keeping up with new information and news can be overwhelming. Below are some of the latest developments surrounding COVID-19 for... By Editorial Team 4 min readBookmark for laterReactions 0 reactions Comments0 comments
COVID-19 Updates, May 7: Remdesivir, Antibody Testing, and Reinfection RiskOur world is still changing every day because of COVID-19. Keeping up with all of the news can be challenging. Here are some of the top COVID-19 updates for people... By Editorial Team 3 min readBookmark for laterReactions 0 reactions Comments0 comments
COVID-19 Updates, April 7: Face Coverings, Testing, & MedicationsIt is common to feel overwhelmed about COVID-19: so much information changing day-to-day. Here are some of the important COVID-19 stories that may be applicable to people living with one... By Editorial Team 3 min readBookmark for laterReactions 0 reactions Comments0 comments
(Closed) Take the Fatigue and Health Survey!The 2020 Fatigue and Health survey has now closed. Thank you for your interest! We are excited to share the results with you soon.Exhaustion, tiredness, weariness... fatigue. We know chronic... By Editorial Team 1 min readBookmark for laterReactions 0 reactions Comments0 comments
FDA Makes Way for Experimental Drugs to Fight COVID-19On March 19, the U.S. Food and Drug Administration (FDA) approved the testing of two drugs, chloroquine (hydroxychloroquine) and remdesivir, to treat people with COVID-19. The drugs have been given... By Editorial Team 3 min readBookmark for laterReactions 0 reactions Comments1 comments
COVID-19: Tips To Reduce Your RiskWith all of the news circulating about the novel (new) coronavirus, it can be easy to feel overwhelmed or anxious. This is especially true if you are immune-compromised due to... By Editorial Team 4 min readBookmark for laterReactions 0 reactions Comments0 comments
COVID-19 Basics for the Immune-CompromisedFor those living with chronic health conditions, current news about the coronavirus (COVID-19) can be anxiety-inducing. We have questions and concerns about how the virus is transmitted, how it can... By Editorial Team 5 min readBookmark for laterReactions 0 reactions Comments1 comments
The American Cancer Society Issues 2020 Report on CancerThe American Cancer Society (ACS) recently released its report, Cancer Statistics, 2020. The report found that the death rate from cancer in the US is dropping. Between 1991 and 2017... By Editorial Team 3 min readBookmark for laterReactions 0 reactions Comments1 comments
Research Shows Cancer Likely to Become More Deadly than Heart DiseaseHeart disease is the leading cause of death in Americans, but new research shows that cancer is likely to surpass heart disease as the number one killer in 2020, especially... By Emily Downward2 min readBookmark for laterReactions 0 reactions Comments0 comments
Higher Suicide Rates Among People with Urologic CancersPeople with urologic cancers – prostate, bladder, and kidney cancers – are five times more likely to commit suicide, according to recent data presented at the European Association of Urology... By Emily Downward2 min readBookmark for laterReactions 0 reactions Comments0 comments
FDA Approves First Treatment for Non-Metastatic CRPCThe FDA last week approved Erleada (apalutamide) as the first treatment for non-metastatic castration-resistant prostate cancer (CRPC). This provides a new treatment approach for men whose cancer has not spread... By BrianM.Green2 min readBookmark for laterReactions 0 reactions Comments1 comments
FDA Expands Treatment Options for Metastatic Prostate CancerYesterday, the FDA approved abiraterone acetate, taken with prednisone, for metastatic high-risk castration-sensitive prostate cancer (CSPC).Abiraterone acetate is an oral tablet licensed by Janssen Biotech under the brand name Zytiga... By BrianM.Green2 min readBookmark for laterReactions 0 reactions Comments1 comments